Cargando…
LSD1 inhibitors disrupt the GFI1 transcription repressor complex
Pharmacologic inhibition of KDM1A (Lysine Demethylase 1A) induces differentiation in certain subtypes of acute myeloid leukemia. Our recent studies reveal this is dependent upon drug-induced disruption of the GFI1 (Growth Factor Independent 1) transcription repressor complex, leading to activation o...
Autores principales: | Maiques-Diaz, Alba, Lynch, James T., Spencer, Gary J., Somervaille, Tim C.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150006/ https://www.ncbi.nlm.nih.gov/pubmed/30250927 http://dx.doi.org/10.1080/23723556.2018.1481813 |
Ejemplares similares
-
LSD1: biologic roles and therapeutic targeting
por: Maiques-Diaz, Alba, et al.
Publicado: (2016) -
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
por: Maiques-Diaz, Alba, et al.
Publicado: (2018) -
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block
por: Maiques-Diaz, Alba, et al.
Publicado: (2022) -
Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia
por: Williams, Mark S., et al.
Publicado: (2020) -
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
por: Lee, Catherine, et al.
Publicado: (2019)